These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16620018)

  • 21. Immunological basis of inflammatory bowel disease: role of the microcirculation.
    Laroux FS; Grisham MB
    Microcirculation; 2001 Oct; 8(5):283-301. PubMed ID: 11687942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease.
    Hatoum OA; Binion DG; Gutterman DD
    Eur J Clin Invest; 2005 Oct; 35(10):599-609. PubMed ID: 16178878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonimmune cells in inflammatory bowel disease: from victim to villain.
    Danese S
    Trends Immunol; 2008 Nov; 29(11):555-64. PubMed ID: 18838297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The protein C pathway in inflammatory bowel disease: the missing link between inflammation and coagulation.
    Lust M; Vulcano M; Danese S
    Trends Mol Med; 2008 Jun; 14(6):237-44. PubMed ID: 18457995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation.
    Danese S; Semeraro S; Marini M; Roberto I; Armuzzi A; Papa A; Gasbarrini A
    Dig Liver Dis; 2005 Nov; 37(11):811-8. PubMed ID: 16168725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental models of mucosal inflammation.
    Strober W; Fuss IJ
    Adv Exp Med Biol; 2006; 579():55-97. PubMed ID: 16620012
    [No Abstract]   [Full Text] [Related]  

  • 27. Cell death in the colonic epithelium during inflammatory bowel diseases: CD95/Fas and beyond.
    Chen L; Park SM; Turner JR; Peter ME
    Inflamm Bowel Dis; 2010 Jun; 16(6):1071-6. PubMed ID: 20049945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction.
    Wagner AH; Güldenzoph B; Lienenlüke B; Hecker M
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):715-20. PubMed ID: 14976003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma.
    Dotan I; Allez M; Nakazawa A; Brimnes J; Schulder-Katz M; Mayer L
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1630-40. PubMed ID: 17347451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bcl-2/caspase 3 mucosal imbalance favors T cell resistance to apoptosis in dogs with inflammatory bowel disease.
    Jergens A; Young J; Moore D; Wang C; Hostetter J; Augustine L; Allenspach K; Schmitz S; Mosher C
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):167-74. PubMed ID: 24495616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?
    Asakura H; Suzuki K; Honma T
    World J Gastroenterol; 2007 Apr; 13(15):2145-9. PubMed ID: 17465491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatment.
    Scaldaferri F; Correale C; Gasbarrini A; Danese S
    Cell Adh Migr; 2009; 3(3):296-9. PubMed ID: 19571660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the endothelium in inflammatory bowel diseases.
    Cromer WE; Mathis JM; Granger DN; Chaitanya GV; Alexander JS
    World J Gastroenterol; 2011 Feb; 17(5):578-93. PubMed ID: 21350707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune-non immune networks in intestinal inflammation.
    Hausmann M; Rogler G
    Curr Drug Targets; 2008 May; 9(5):388-94. PubMed ID: 18473767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of dendritic cells in the pathogenesis of inflammatory bowel disease.
    Leon F; Smythies LE; Smith PD; Kelsall BL
    Adv Exp Med Biol; 2006; 579():117-32. PubMed ID: 16620015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production.
    Liu Z; Colpaert S; D'Haens GR; Kasran A; de Boer M; Rutgeerts P; Geboes K; Ceuppens JL
    J Immunol; 1999 Oct; 163(7):4049-57. PubMed ID: 10491009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment.
    Veltkamp C; Anstaett M; Wahl K; Möller S; Gangl S; Bachmann O; Hardtke-Wolenski M; Länger F; Stremmel W; Manns MP; Schulze-Osthoff K; Bantel H
    Gut; 2011 Oct; 60(10):1345-53. PubMed ID: 21459928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral and intestinal CD4+ T cells with a regulatory phenotype in pediatric patients with inflammatory bowel disease.
    La Scaleia R; Morrone S; Stoppacciaro A; Scarpino S; Antonelli M; Bianchi E; Di Nardo G; Oliva S; Viola F; Cucchiara S; Santoni A; Palmieri G; Uccini S
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):563-72. PubMed ID: 20890221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation.
    Danese S; Dejana E; Fiocchi C
    J Immunol; 2007 May; 178(10):6017-22. PubMed ID: 17475823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleiotropic functions of TNF-α in the regulation of the intestinal epithelial response to inflammation.
    Leppkes M; Roulis M; Neurath MF; Kollias G; Becker C
    Int Immunol; 2014 Sep; 26(9):509-15. PubMed ID: 24821262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.